WHO: Latest 2024-2025 Influenza Vaccine Strain Recommendations

• Facebook
• Twitter
• Reddit
• Tumblr
• LinkedIn
• Pinterest
• RSS Feed
• Link

WHO: Latest 2024-2025 Influenza Vaccine Strain Recommendations

• Shocking! All existing AIDS vaccine developments have failed 
• Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
• CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
• FDA has mandated a top-level black box warning for all marketed CAR-T therapies
• Can people with high blood pressure eat peanuts?
• What is the difference between dopamine and dobutamine?
• How long can the patient live after heart stent surgery?

WHO: Latest 2024-2025 Influenza Vaccine Strain Recommendations

The influenza virus can cause seasonal flu and even pandemics. It is an RNA virus with a complex classification and many subtypes, making it prone to mutations.

Vaccination is widely recognized as the best way to prevent the flu.

To ensure vaccine effectiveness, the World Health Organization (WHO) updates the vaccine strain components annually.

Changes in the 2024-2025 Northern Hemisphere Influenza Vaccine Strain Composition

To maintain vaccine effectiveness, it is necessary to regularly update the influenza virus vaccine components.

After analyzing global influenza virus epidemiology, pathogenesis, and vaccine serology, WHO announced the 2024-2025 Northern Hemisphere Influenza Vaccine Strain Recommendations on February 23, 2024.

Trivalent Chicken Embryo Cultured Vaccines:

• an A/Victoria/4897/2022 (H1N1)pdm09-like virus
• an A/Thailand/8/2022 (H3N2)-like virus
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus

Trivalent Cell-Cultured or Recombinant Protein Vaccines:

• an A/Wisconsin/67/2022 (H1N1)pdm09-like virus
• an A/Massachusetts/18/2022 (H3N2)-like virus
• a B/Austria/1359417/2021 (B/Victoria lineage)-like virus

Quadrivalent Chicken Embryo and Cell-Cultured or Recombinant Protein Vaccines (added to the trivalent vaccine components):

• a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus Since March 2020, no naturally occurring B/Yamagata lineage virus has been confirmed. WHO considers it unnecessary to include the B/Yamagata lineage virus as a component of influenza vaccines and recommends its removal from influenza vaccine components. In areas still using quadrivalent vaccines, the inclusion of the B/Yamagata lineage component remains consistent with previous recommendations.

Comparison of 2023-2024 and 2024-2025 Northern Hemisphere Influenza Vaccine Strain Components reveals the main difference in the H3N2 virus strains:

Recombinant Antigens are Key Materials for Vaccine Research

Critical target antigens play an important role in influenza virus-related vaccines, drugs, and even diagnostic reagents. Below, we have organized information on HA, NA, and NP proteins.

Recombinant antigens from influenza vaccine strains can be applied in various stages of vaccine development, such as vaccine content testing, vaccine biological potency testing, and toxicity testing. Using recombinant antigens for ELISA testing can analyze the levels of total antibodies and neutralizing antibodies in immune sera after vaccination, and detect vaccine content using recombinant proteins as controls.

Using recombinant influenza HA protein to detect serum antibody levels in mice after vaccine immunization (picture from Andersen, et al.)

WHO: Latest 2024-2025 Influenza Vaccine Strain Recommendations

References:

[1]https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2024-2025-northern-hemisphere-influenza-season

[2] Andersen, et al. Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief.[J]. Frontiers in Immunology.2021.747032.

[3] Bangaru S , et al. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface[J]. Cell, 2019.

[4] Kim M , et al. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.[J]. Antiviral Research, 2013, 100(2):460-472.

(source:internet, reference only)

Disclaimer of medicaltrend.org

Important Note: The information provided is for informational purposes only and should not be considered as medical advice.